S11-1 Toxicology on Regulatory Sciences ; Interpretation of Definition and Signiflcance of NOAEL (No Observed Adverse Effect Level) for Pharmaceuticals(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2004-10-29
著者
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Kadota Toshihito
Nippon Boehringer Ingelheim Co. Ltd.
-
Kadota Toshihito
Nippon Boehringer Ingelheim Co. Ltd.:japan Pharmaceutical Manufactures Association (jpma)
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
関連論文
- Comparison of enhancing effects of different goitrogen treatments in combination with β-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds
- LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
- Lack of Modifying Effects of Cinnamaldehyde on Development of Lung Proliferative Lesions Induced by Urethane in Transgenic Mice Carrying the Human Prototype c-Ha-ras Gene
- Inhibiting Effects of Ethinylestradiol on N-ethyl-M-nitrosourea-Initiated Uterine Carcinogenesis in Transgenic Mice Carrying a Human Prototype C-Ha-ras Gene (rasH2 mice) (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th A
- Promoting Effects of Ethinylestradiol but not Atrazine on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in ICR Mice
- Difference in the Types of Uterine Tumors between Heterozygous p53-deficient and Wild Type CBA Mice Treated with Ethinylestradiol after N-ethyl-N-nitrosourea Initiation
- Modifying effect of atrazine on DMBA-induced mammary carcinogenesis in ovariectomized rats.(GENERAL SESSION BY POSTER PRESENTATION)(CARCINOGENICITY)
- Modifying Effects of Genistein, 4-Nonylphenol and Methoxychlor on N-ethyl-N-nitrosourea-induced Uterine Carcinogenesis in RasH2 Transgenic Mice Harboring a Human Prototype C-Ha-ras Gene
- Enhancing Effects β-Estradiol 3-Benzoate but Not Methoxychlor on the Promotion/Progression Stage of Chemically-induced Mammary Carcinogenesis in Ovariectomized Rats
- GONADAL TOXICITY OF AN ETHANOL EXTRACT OF PSORALEA CORYLIFOLIA IN A RAT 90-DAY REPEATED DOSE STUDY
- The Utility of N-nitrosamines as Initiators for a 26-Week Rat Two-Stage Nasal Carcinogenesis Model
- "C-6 Evaluation of Rat Hepatotoxicity on Benzimidazole Compounds Using Gap Junctional Intercellular Communication Protein, Connexin 32.
- Induction of Squamous Cell Carcinomas in the Salivary Glands of Rats by Potassium Iodide
- Possible enhancing effects of atrazine on growth of 7, 12-dimethylbenz(a) anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- Points to consider on the non-clinical safety evaluation of anticancer drugs
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- "POINTS TO CONSIDER" REGARDING SAFETY ASSESSMENT OF BIOTECHNOLOGY-DERIVED PHARMACEUTICALS IN NON-CLINICAL STUDIES (ENGLISH TRANSLATION)
- MECHANISTIC STUDY ON INHIBITION OF SERUM THYROID HORMONE PRODUCTION BY THIOUREA
- TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM LEVELS OF RELATED HORMONES IN RATS TREATED WITH KOJIC ACID AFTER DHPN INITIATION
- IMMUNOHISTOCHEMICAL STUDIES OF TSH-PRODUCING CELLS IN THE PITUITARY AND EXPRESSION OF GROWTH FACTORS IN THYROIDAL PROLIF-ERATIVE LESIONS IN RATS TREATED WITH THIOUREA AND EXCESS VITAMIN A
- "P-42 Protective Effect of Lecithinization-Superoxide Dismutase Against Monocrotaline Induced Lung Injuries
- "P-41 A Morphometric study on the time course change of thyrotroph hypertrophy in the pituitary of rats treated with a goitrogen.
- Lack of Modifying Effects of NNK on Lung Tumorigenesis in Hamsters with Pulmonary Fibrosis Induced by MNUR
- DOSE-THRESHOLD FOR THYROID TUMOR-PROMOTING EFFECTS OF ORALLY AMINISTERED KOJIC ACID IN RATS AFTER INITIATION WITH N-bis(2-HYDROXYPROPYL) NITROSAMINE
- Review of an alternative to animal testing for safety evaluation of Quasi-drug
- P-39 Effect of t-buthylhydroquinone and sodium nitrite alone or in combination on the forestomach of rasH2 mice.(Proceedings of the 27th Annual Meeting)
- P-38 Carcinogenic susceptibility of phenolphthalein in heterozygous p53 deficient C57BL/6 and CBA mice.(Proceedings of the 27th Annual Meeting)
- TOXICITY AND BLOOD CONCENTRATIONS OF XYLAZINE AND ITS METABOLITE, 2, 6-DIMETHYLANILINE, IN RATS AFTER SINGLE OR CONTINUOUS ORAL ADMINISTRATIONS
- 21C-11-2 Modifying Effects of Xylazine on Rat Nasal Carcinogenesis.
- 21WA-01-4 Modifying Effects of Endocrine Disrupting Chemicals to Thyroid Proliferative Lesions in Ovariectomized Rats.
- Absence of Tumor Promoting Activity of Xylazine in a Two-stage Nasal Carcinogenesis Model in N-bis(2-hydroxypropyl)nitrosamine-treated Rats
- O11-12 Modifying effects of endocrine disrupting chemicals on ENU-induced uterine carcinogenesis in heterozygous p53 deficient CBA mice.
- P-67 Early changes of thyroid and in rats given a single administration of diisopropanolnitrosamine.(Proceedings of the 27th Annual Meeting)
- O-14 Mechanistic studies on testicular toxicity of Psoralea corylifolia extract in rats.(Proceedings of the 27th Annual Meeting)
- 21C-10-3 Susceptibility of p53 heterozygous knockout CBA mice to carcinogenic substances.
- 3A-19 A Mechanistic Study on Ovarian Carcinogenesis of Nitrofurazone in Mice
- 3A-16 Toxicological significance of the metabolite, 2,6-xylidine, in rats treated with a parent drug, xylazine
- 3A-06 Study on the Thyroid Tumor Promotion Effect of Kojic Acid
- Preventive Effects of Shinchimotsu-koka-to on Renal Lesions in Stroke-Prone Spontaneously Hypertensive Rats
- MORPHOLOGICAL EVALUATION OF CYCLOPHOSPHAMIDE TESTICULAR TOXICITY IN RATS USING QUANTITATIVE MORPHOMETRY OF SPERMATOGENIC CYCLE STAGES
- EFFECTS OF BARBITAL ON NEURO-ONCOGENESIS IN A TRANSPLACENTAL CARCINOGENICITY MODEL USING F344 RATS
- STUDY OF EXAMINATION METHODS FOR ASSESSING MALE FERTILITY DISTURBANCES 1.QUANTITATIVE MORPHOMETRICAL EVALUATION OF TESTICULAR TOXICITY OF ADRIAMYCIN
- Question and Answer on Toxicity 2003 : How far have methods for toxicity assessment been harmonized? (WORKSHOP4: QUESTION AND ANSWER ON TOXICITY 2003; HOW FAR HAVE METHODS FOR TOXICITY ASSESSMENT BEEN HARMONIZED?) (Proceedings of the 30th Annual Meeting)
- Preclinical safety studies of anticancer agents : Cytotoxic agents(Breaking Through the Stage of Non-clinical to Clinical in the Drug Development Process, Proceedings of the 32nd Annual Meeting)
- S11-6 "6. Closing and Summary"(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE OF NOAEL (NON-OBSERVED ADVERSE EFFECT LEVEL) FOR PHARMACEUTICALS)(Proceedings of the 31st Annual Meeting)
- S11-1 Toxicology on Regulatory Sciences ; Interpretation of Definition and Signiflcance of NOAEL (No Observed Adverse Effect Level) for Pharmaceuticals(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE
- S11-5 "5. Q&A and Discussion"(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE OF NOAEL (NON-OBSERVED ADVERSE EFFECT LEVEL) FOR PHARMACEUTICALS)(Proceedings of the 31st Annual Meeting)
- Summary of the workshop "The Pre-Clinical Safety Evaluation of Biotechnology : Derived Pharmaceuticals"(WORKSHOP 1 : THE WAY TOXICITY EVALUATIONS OF BIO-PHARMACEUTICAL PRODUCTS SHOULD BE CONDUCTED (TOXICOLOGICAL QUESTIONS & ANSWERS-ISSUE 2002).ICH-S6)
- Perspectives on non-clinical safety evaluation of drug metabolites through the JSOT workshop